The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol

How To Fix Hepatitis

Here's a taste of what has to offer on this topic:
Ask the Experts

'll fix an international card to donate

Hello Doctor, first sorry for my English, it is possible 7 anti hiv testing of fourth generation (137dias, 205dias, 256dias, 286dias, 301dias, 320dias, 383dias) made in three different laboratories do not detect the infection? Should not produce...
Robert J. Frascino, M.D.

Response from Robert J. Frascino, M.D.

The Robert James Frascino AIDS Foundation
Hi,Your repeatedly negative fourth generation HIV-antibody/antigen tests out to 383 days are definitive, conclusive and WOO-HOO-able! HIV is not your problem. No way. No how. No additional HIV testing is warranted. Your other tests (VDRL, hepatitis... Read more »

Hepatitis vaccine & ELISA - confused, please help!

Hello Dr. Bob,First, I would like to thank you for providing such an incredible resource to the... Read more »

about hepatitis b vaccine

Hello Madam....i am a hep b person. my test was found positive. due to my financial condition i... Read more »
U.S. Centers for Disease Control and Prevention

Vancouver's Heroin "Fix"

In a move that angers US officials fighting drugs, the city of Vancouver, British Columbia, is opening North America's first safe injection sites for heroin users. The sites are modeled after facilities in existence for more than a decade in some... Read more »
Bristol-Myers Squibb Company and Gilead Sciences, Inc.

Bristol-Myers Squibb and Gilead Announce Data Supporting Bioequivalence for Single-Pill Fixed-Dose Regimen of Sustiva (Efavirenz) and Truvada (Emtricitabine and Tenofovir Disoproxil Fumarate)

New York, NY and Foster City, CA -- Bristol-Myers Squibb Company (NYSE: BMY) and Gilead Sciences, Inc. (Nasdaq: GILD) today announced they have obtained data supporting bioequivalence of a new formulation of the fixed-dose combination of... Read more »
U.S. Food and Drug Administration

Approval of Complera: Emtricitabine/Rilpivirine/Tenofovir DF Fixed-Dose Combination

On August 10, 2011, FDA approved Complera TM , a fixed dose combination (FDC) drug product containing emtricitabine/rilpivirine/tenofovir DF (FTC/RPV/TDF) for the treatment of HIV. The recommended dose of Complera TM is one tablet, containing... Read more »
HIV i-Base

Quad Fixed-Dose Integrase Combination: Phase 3 Studies at Week 48

The fixed dose, single-pill, four-drug formulation of elvitegravir/cobicistat/tenofovir/FTC, developed under the name Quad, is likely to be closest to regulatory approval (and has an FDA hearing in May). At CROI, results were presented from two... Read more »
Connect With Others

In a bit of a fix...

Posted by Anonymous, 3 Replies
Hi there,

I posted a couple of weeks back about my drunken unprotected sex with a guy I had a one night stand with at Christmas who I later found out had been VERY promiscuous whilst travelling a couple of years back..
Anyway, had test after 4 weeks... Read more »

Periodo ventana de la hepatitis b y c

Posted by mariana, 1 Reply
hola quiero saber cuanto es el periodo ventana de la hepatitis b y de la hepatitis c con tecnicas de busqueda de anticuerpos no de adn, quiero saber cuandoes definitivo el examen de hepatitis b y c con la tecnica de anticuerpos. Read more »

periodo ventana en coinfeccion hepatitis c??

Posted by Anonymous, 1 Reply
por favor, ya no se que pensar. si alguien como yo a los 6 meses tiene una serologia negativa de vih y posituva de hepatitis c pero con arn hepatitis indetectable, no es segura la prueba del vih por uan posible coinfeccion? se alarga el periodo... Read more »

Co infeccion ( vih/hepatitis C ) elisa 12 meses?

Posted by mariana, 1 Reply
En el caso de que el virus de la hepatitis C haya sido adquirido en el mismo riesgo en el cual se adquiere vih, las pruebas de vih y hepatitis C podrian ser negativas hasta los 12 meses.

Se han visto casos en que el VHC examen de anticuerpos no... Read more »